29 March 2020 - 5 Nisan 5780 - ה' ניסן ה' אלפים תש"פ
Hong Kong-based Baring Private Equity acquires Lumenis E-mail

Baring Private Equity Asia (BPEA) recently announced that its affiliated funds have agreed to acquire Israel-based Lumenis Ltd. – a maker of minimally-invasive clinical devices for aesthetics, urology, and ophthalmology – from XIO Group.

In 2015, Lumenis was acquired for some US$510 million by XIO Group, which delisted the firm’s shares from the Nasdaq exchange.

Lumenis has developed and commercialised innovative energy-based technologies, including lasers such as intense pulsed light (IPL) and radiofrequency (RF).

Some 30 years ago the firm developed the world’s first holmium surgical laser to blast urinary stones located in the kidneys, bladder, or in between.

It recently developed new technology called “Moses”, that the Israeli company says is even more effective than its original urology lasers, and is considered a ‘game changer’, in the treatment of urinary stones.

The deal values Lumenis at over US$1 billion, the two companies said in a statement.

Founded in 1973, the company has a presence in over 100 countries and close to 1,500 employees worldwide.

Please login or register to see the full article

Warning: Parameter 1 to modMainMenuHelper::buildXML() expected to be a reference, value given in /home/joomla789/domains/jewishtimesasia.org/public_html/libraries/joomla/cache/handler/callback.php on line 99
Jewish Times Asia is published by Jewish Times Asia Ltd. © Copyright 2020.
Material in the newspaper or on this site may not be used or reproduced in any form or in any way without permission from the editor.
While every effort has been made to ensure the content is true and accurate, the publisher is not responsible for any errors or omissions in the printed text.